Skip to main content
SpringerLink
Log in

Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Paschka P, Marcucci G, Ruppert AS, Mrozek K, Chen H, Kittles RA et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol 2006; 24: 3904–3911.

    Article  CAS  Google Scholar 

  2. Marcucci G, Caligiuri MA, Dohner H, Archer KJ, Schlenk RF, Dohner K et al. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia. Leukemia 2001; 15: 1072–1080.

    Article  CAS  Google Scholar 

  3. Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E et al. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia 2002; 16: 1176–1181.

    Article  CAS  Google Scholar 

  4. Perea G, Lasa A, Aventin A, Domingo A, Villamor N, Queipo de Llano MP et al. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia 2006; 20: 87–94.

    Article  CAS  Google Scholar 

  5. Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W . New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 2003; 102: 2746–2755.

    Article  CAS  Google Scholar 

  6. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—a Europe Against Cancer program. Leukemia 2003; 17: 2318–2357.

    Article  CAS  Google Scholar 

  7. Boissel N, Leroy H, Brethon B, Philippe N, de Botton S, Auvrignon A et al. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia 2006; 20: 965–970.

    Article  CAS  Google Scholar 

  8. Stentoft J, Hokland P, Ostergaard M, Hasle H, Nyvold CG . Minimal residual core binding factor AMLs by real time quantitative PCR—initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse. Leuk Res 2006; 30: 389–395.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the North-West Canceropole (Onco-Hematology Axis) and the Fondation de France (Leukemia Committee).

Author information

Authors and Affiliations

  1. Service des Maladies du Sang, CHRU de Lille, Lille, France

    R Guièze

  2. Inserm, U837, Team 3, Lille, France

    R Guièze, A Renneville, M Cheok & C Preudhomme

  3. University of Lille Nord de France, Lille, France

    R Guièze, A Renneville & C Preudhomme

  4. University of Clermont 1, EA3846, Clermont-Ferrand, France

    R Guièze

  5. CHU de Clermont-Ferrand, Hôtel-Dieu, Service d’Hématologie Clinique Adulte et de Thérapie Cellulaire, Clermont-Ferrand, France

    R Guièze

  6. Institut de Recherche sur le Cancer de Lille, Lille, France

    A Renneville, M Cheok & C Preudhomme

  7. Laboratoire d’Hématologie, CHRU de Lille, Lille, France

    A Renneville & C Preudhomme

  8. Hématologie Biologique, Hôpital Saint-Louis, Université Paris 7, Paris, France

    J-M Cayuela & F Sigaux

  9. Hématologie Biologique, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France

    R B Abdelali & E A Macintyre

  10. EA 3518, Université de Paris 7,

    N Boissel & H Dombret

  11. Hématologie Adulte, Hôpital Saint-Louis, Paris, France

    N Boissel & H Dombret

  12. Hématologie Clinique, Institut Gustave Roussy, Villejuif, France

    S de Botton

  13. Service d’Hématologie Clinique adultes, Hôpital Necker AP-HP, Université Paris Descartes, Paris, France

    M-T Rubio

  14. Hématologie Pédiatrique, Hôpital Jeanne de Flandres, CHRU de Lille, Lille, France

    F Mazingue

  15. Service d’Hématologie Clinique, Hôpital Avicenne, Université Paris 13, Bobigny, France

    P Fenaux

Authors
  1. R Guièze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Renneville
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J-M Cayuela
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R B Abdelali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Boissel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S de Botton
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M-T Rubio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Mazingue
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E A Macintyre
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Cheok
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F Sigaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. P Fenaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. H Dombret
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. C Preudhomme
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Preudhomme.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guièze, R., Renneville, A., Cayuela, JM. et al. Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience. Leukemia 24, 1386–1388 (2010). https://doi.org/10.1038/leu.2010.112

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.112

  • Springer Nature Limited

This article is cited by

Search

Navigation